Why the markets see trouble ahead for the US.
Deep within Trump’s latest bill lies Section 899 — a quiet clause with global consequences.
Good morning! Pharma execs are sweating bullets this week as Trump’s latest drug pricing proposal threatens to drain a staggering $1 trillion from their pockets.
Today, we're diving into UPS’s plan to cut 20,000 jobs — and how European banks are the unlikely beneficiaries of Trump’s trade policies.
We're diving into Tesla's latest financial woes and the political turbulence causing headaches for Elon Musk
Markets are rattled. Bonds are shaky. Discover why global confidence in the U.S. economy is slipping—and how it affects you.
Stocks are plunging worldwide—tech giants and investors brace as Trump's latest tariff moves spark chaos. Here's what you need to know.
